Demographics (2)
- Age - Disease onset age (phv00202809.v1.p1)
- sex - Gender of participant (phv00202812.v1.p1)
Disease Events (5)
- AFFECTION_STATUS - Case control status of the subject (phv00202802.v1.p1)
- FAB - French - American - British AML classification designation (see: <a href="http://www.cancer.org/cancer/leukemia-acutemyeloidaml/detailedguide/leukemia-acute-myeloid-myelogenous-classified">Cancer.org</a>) (phv00202811.v1.p1)
- IS_TUMOR - AML status (phv00202818.v1.p1)
- TUMOR_GRADE - Leukemia stage of sample (M2, M4, biphenotypic, N/A - see: <a href="http://www.cancer.org/cancer/leukemia-acutemyeloidaml/detailedguide/leukemia-acute-myeloid-myelogenous-classified">Cancer.org</a>) (phv00202819.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00202820.v1.p1)
Other (18)
- ANALYTE_TYPE - Analyte Type (phv00202817.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00202816.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00202799.v1.p1)
- Death Time - Time between sample obtained and death (phv00202813.v1.p1)
- GENOTYPING_CENTER - Name of the center which conducted genotyping (phv00202821.v1.p1)
- Relapse Time - Time between sample obtained and relapse (phv00202814.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00202815.v1.p1)
- SAMPLE_ID - Sample ID (phv00202804.v1.p1)
- SAMPLE_SOURCE - Source repository where samples originate (phv00202805.v1.p1)
- Sample_time - Time when sample was taken: D=Diagnosis; R=Relapse (phv00202810.v1.p1)
- SAMPLE_USE - Sample Use (phv00202807.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00202822.v1.p1)
- SOURCE_SAMPLE_ID - Sample ID used in the Source Repository (phv00202806.v1.p1)
- SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00202801.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00202808.v1.p1)
- SUBJECT_ID - Subject ID (phv00202798.v1.p1)
- SUBJECT_ID - Subject ID (phv00202803.v1.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00202800.v1.p1)